Laura Torres-Miñana

Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study

Naval Daver, Pau Montesinos, Daniel J. DeAngelo et al. · The Lancet Oncology · 2024 · 63 citations · Full text

Medicine, Oncology, Pharmacology +16

Management of acquired hemophilia A: results from the Spanish registry

María Eva Mingot‐Castellano, José Pardos‐Gea, Saturnino Haya et al. · Blood Advances · 2021 · 39 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation

María M. Perera, Laura Torres-Miñana, María José Pena-López · Bone Marrow Transplantation · 2017 · 22 citations · Full text

Medicine, Infectious Diseases, Microbiology +16

Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

Blanca Boluda, Antonio Solana‐Altabella, Isabel Cano et al. · Cancers · 2023 · 16 citations · Full text

Medicine, Hematology, Oncology +14

A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients

María Pilar Sánchez, Juan Eduardo Megías‐Vericat, Rebeca Rodríguez‐Veiga et al. · Annals of Hematology · 2021 · 14 citations

Medicine, Hematology, Oncology +9